文献速递角膜与眼表疾病白内障与屈光手术

眼科手术前局部抗菌剂减少眼表细菌负荷:一项随机对照试验

Topical Antiseptics in Minimizing Ocular Surface Bacterial Load Before Ophthalmic Surgery: A Randomized Controlled Trial.
PubMed 文献 · Am J Ophthalmol · 2024-01-10

这项随机对照试验将70例接受超声乳化手术的成人患者随机分为0.6%聚维酮碘(PVI)组和0.02%氯己定(CLX)组,术前每日4次用药3天,以未治疗眼为对照,用实时PCR定量结膜囊细菌DNA。结果显示CLX组CT值变化显著而PVI组不显著,CLX组眼表细菌负荷下降更明显且耐受性更好,两组菌群分类组成均无显著改变。

要点

  • CLX 0.02%组T0-T1的CT值差异显著(P < .001),PVI 0.6%组不显著(P = .09)。
  • CLX组报告治疗相关眼部症状的患者比例和平均不适评分均低于PVI组。
  • 两组各时间点菌群分类组成及α、β多样性保持一致。

核心结论

  • 与PVI 0.6%相比,CLX 0.02%引起眼表细菌负荷更大幅度的下降,且菌群分类组成无显著改变。
  • CLX的耐受性优于PVI。

研究设计与样本

  • 随机对照试验,纳入70例接受眼内手术(超声乳化)的成人患者。
  • 指数眼随机接受PVI 0.6%(A组)或CLX 0.02%(B组),每日4次、术前连用3天;未治疗眼作为对照。
  • 治疗前后(T0、T1)双眼取结膜拭子,用实时PCR定量微生物DNA,并以Mick算法比较各菌属丰度。
  • 主要结局为T1时细菌DNA较对照臂的减少量,以实时PCR循环阈值(CT)均值表示;次要结局为分类组成、差异丰度和治疗引起的眼部症状。

主要发现

  • B组T0-T1的CT差异显著(均值[95%CI] 0.99[0.33] vs 0.26[0.15],P < .001),A组不显著(0.65[0.3] vs 0.45[0.41],P = .09)。
  • 两组各时间点菌群分类组成及α、β多样性保持一致。
  • A组报告治疗相关眼部症状的患者比例高于B组(97% vs 26%),平均不适评分也高于B组(4.97±2.48 vs 0.66±1.53)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the reduction of the ocular surface bacterial load induced by 2 commercially available ophthalmic antiseptic formulations, povidone-iodine (PVI) 0.6% and chlorhexidine (CLX) 0.02%, before ocular surgery. DESIGN: Randomized controlled trial. METHODS: Seventy adult patients undergoing intraocular surgery (phacoemulsification) were randomized to receive in the index eye PVI (group A) 4 times a day for 3 days or CLX (group B) 4 times a day for 3 days before surgery. The untreated eye was used as control. A conjunctival swab was taken in both eyes before (T0) and after (T1) therapy. Microbial DNA was quantified with real-time polymerase chain reaction (PCR) analysis. The Mick algorithm was used to compare the abundance of each genus/genera against the distribution of abundances from the reference. At T1, patients filled a questionnaire to evaluate therapy-induced symptoms. Primary outcome was the reduction of bacterial DNA at T1 (microbial load), vs control arm, expressed as mean number of real-time PCR cycle times (CTs). Secondary outcomes were taxonomic composition, differential abundance, and therapy-induced ocular symptoms. RESULTS: The T0-T1 difference in CT was significant in group B, but not in group A (mean [95% CI], 0.99 [0.33] vs 0.26 [0.15], P < .001, and 0.65 [0.3] vs 0.45 [0.41], P = .09, respectively). The taxonomic composition, alpha, and beta diversity remained consistent at all time points in both groups. The rate of patients reporting therapy-induced ocular symptoms and the mean discomfort grade were greater in group A than in group B (97% vs 26% and 4.97±2.48 vs 0.66±1.53, respectively). CONCLUSIONS: Compared with PVI 0.6%, CLX 0.02% induced a greater reduction of ocular surface bacterial load, with no significant alterations of the taxonomic composition. Moreover, CLX was better tolerated than PVI.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Romano V, Ferrara M, Gatti F, et al. Topical Antiseptics in Minimizing Ocular Surface Bacterial Load Before Ophthalmic Surgery: A Randomized Controlled Trial. Am J Ophthalmol. 2024. PMID: 38211781. doi:10.1016/j.ajo.2024.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。